Evaluation of CYP2D6 and efficacy of tamoxifen and raloxifene in women treated for breast cancer chemoprevention: Results from the NSABP P1 and P2 clinical trials

S. Day, T. B. Bevers

Research output: Contribution to journalComment/debatepeer-review

Fingerprint

Dive into the research topics of 'Evaluation of CYP2D6 and efficacy of tamoxifen and raloxifene in women treated for breast cancer chemoprevention: Results from the NSABP P1 and P2 clinical trials'. Together they form a unique fingerprint.